The Effect of Neoadjuvant Chemotherapy on Physical Functions
NCT ID: NCT06986005
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
46 participants
OBSERVATIONAL
2025-01-08
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sexual Functıon in Young Women After Breast Cancer Surgery
NCT06966791
The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions
NCT04979715
Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer
NCT06266312
Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer
NCT04623554
Effects of Interpectoral-Pectoserratus Plane Block After Breast Cancer Surgery
NCT05568589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data will be analysed with SPSS 25.0 package programme. Continuous variables will be given as mean ± standard deviation and categorical variables as number and percentage. When parametric test assumptions are met, the Significance Test of the Difference Between Two Means will be used to compare independent group differences; when parametric test assumptions are not met, the Mann-Whitney U test will be used to compare independent group differences. In dependent group comparisons, repeated measures analysis of variance will be used when parametric test assumptions are met; Friedman test will be used when parametric test assumptions are not met. In addition, the relationships between continuous variables will be examined by Spearman or Pearson correlation analyses and the differences between categorical variables will be examined by Chi-square analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast cancer patients receiving neoadjuvant chemotherapy
Breast cancer patients who receiving neoadjuvant chemotherapy
No intervention will be performed as part of this study. However, regardless of the study, all participants will receive neoadjuvant chemotherapy.
All participants will receive neoadjuvant chemotherapy appropriate to the characteristics of their breast cancer as part of their standard care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention will be performed as part of this study. However, regardless of the study, all participants will receive neoadjuvant chemotherapy.
All participants will receive neoadjuvant chemotherapy appropriate to the characteristics of their breast cancer as part of their standard care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acceptance to participate in the study
Exclusion Criteria
* History of any other cancer
* Refusal to participate in the study
* Refusal to continue working
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ATİYE KAŞ ÖZDEMİR
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ATİYE KAŞ ÖZDEMİR
Lecturer PhD.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pamukkale University
Denizli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-60116787-020-642610
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.